| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |